21/12/2017 05:38 AST

Waha Capital, a leading Abu Dhabi-based investment company, through its UAE healthcare subsidiary Anglo Arabian Healthcare (AAH) has completed the sale of its full equity stake in Proficiency Healthcare Diagnostics (PHD) to Al Borg Medical Laboratories, the GCC's largest chain of private laboratories.

The transaction, which was previously announced on May 21, 2017, involves an equity sale price of approximately Dh184 million for 100 per cent of PHD, with the net impact on Waha Capital being an accounting gain of approximately Dh94 million which will be recorded in the company's Q4 2017 financial statements, Waha said.

AAH acquired a 70 per cent stake in PHD in April 2013 and then increased its stake in the business to 93 per cent. During the holding period, PHD solidified its position as a leading independent diagnostic services provider in the UAE. The company has expanded its footprint since AAH's acquisition by adding new branches in Al Ain, Dubai and the Western Region, which led to a more than doubling of revenues and earnings since 2013.

"Waha Capital entered PHD at a key stage in the company's growth trajectory, supporting the business in achieving impressive scale," said Salem Rashid Al Noaimi, Chief Executive Officer and Managing Director of Waha Capital.

Al Noaimi added: "The transaction crystalises significant value creation achieved by Waha Capital and AAH. We look forward to delivering more success under AAH as we continue to expand the group's scale in the premium and affordable care segments."

Dr Fawaz Al Bishri, Chairman of Al Borg Medical Laboratories, said: "The two companies are leaders in their respective markets and the combined company in the UAE, with a network of 12 laboratories, will be a clear market leader in the private independent laboratory space. Such a combination will allow Al Borg and PHD to benefit from synergies and greater scale, thereby allowing us to accelerate our growth plans across the Middle East."

Anglo Arabian Healthcare, which is a seed asset in Waha Capital's private equity business, operates multiple healthcare platforms with 35 healthcare assets across Abu Dhabi, Dubai, Sharjah, Ajman and Ras Al Khaimah.

Al Borg Medical Laboratories is the largest private laboratory chain in the GCC, offering a wide range of routine and specialty tests to individuals, hospitals, clinics, insurance companies and corporates. As of December 2016, the company had 52 laboratories, 1,150 personnel, and conducted over 7.5 million tests across eight countries in the GCC and Africa.


Trade Arabia

Waha Capital AGM approves 17.5 per cent dividend

27/03/2018

Shareholders of Waha Capital approved a cash dividend of 17.5 fils per share, equivalent to 17.5 per cent of its paid-up capital at the company's Annual General Meeting (AGM) on Sunday. The company h

Gulf News

Waha Capital proposes 15pc cash dividends

20/02/2018

Waha Capital, a leading Abu Dhabi-based investment company, said its board has recommended a cash dividend of 15 fils per share, equivalent to 15 per cent of its paid-up capital.

The divid

Trade Arabia

Waha Capital net profit rises 4.6pc to $116m

30/01/2018

Waha Capital, a leading investment company based in Abu Dhabi, has reported a preliminary net profit of Dh425.9 million ($115.96 million), an increase of 4.6 percent from a year earlier, due to gains

Trade Arabia

Ticker Price Volume
ALRAMZ 1.57 0
WAHA Sector Market
Price/BookValue
Dividend Yield (%)
Relative Strength
  • 1-Month
  • 3-Month
  • 1-Year
Volume Change
  • 10D Avg Vs 90D Avg
Price Vs…
  • 52-w high
  • 50-day moving avg.
  • 200-Day Moving Avg
Ticker Price Change
IHC 407.00 -5.90 (-1.43%)
FAB 13.58 -0.18 (-1.31%)
EMIRATESNBD 20.35 0.10 (0.49%)
DIB 6.28 0.08 (1.29%)
ADCB 8.68 0.00 (0.00%)
EEC's capital optimization plan to shore up financial position and sustain growth: CEO

14/09/2024

RIYADH: Saudi master developer Emaar The Economic City's SR8.7 billion ($2.32 billion) capital optimization plan is a "strategic response" to its current financial challenges, according to its CEO. <

Saudi Gazette

Arabian Mills set final IPO price at $17.59 per share as CEO details growth vision

12/09/2024

Saudi wheat flour producer Arabian Mills for Food Products Co. has set its final initial public offering price at SR66 ($17.59) per share on the Tadawul main market. During the book-building proces

Arab News

SABIC-MCC joint venture starts output

04/05/2018

SABIC announced the successful completion of the pilot operation of the Methyl Methacrylate Monomer (MMA) and Poly Methyl Methacrylate (PMMA) plants and the commencement of commercial operations.

Saudi Gazette

S&P affirms QIB rating at A-

05/04/2018

Standard & Poor's (S&P) has affirmed QIB's Issuer Credit Rating at A-, Qatar's leading Islamic bank has said in a release. According to S&P, the major contributing factors strengthening QIB's rating

Gulf Times

Qatar National Bank seeks growth in Southeast Asia

05/04/2018

Qatar National Bank (QNB) aims to increase its profit by 5-8 percent this year and loans and investments by 10-12 percent, helped by expansion into faster-growing Southeast Asia markets, its CEO told

The Peninsula